UK researchers have shown that screening children for type 1 diabetes can detect the condition early, preventing emergencies and enabling access to treatments that delay the need for insulin. A major UK research programme has shown that screening children for type 1 diabetes (T1D) can detect the condition years before symptoms appear—dramatically reducing the risk of life-threatening emergencies at diagnosis and giving families time to prepare, plan, and access emerging treat

Researchers in the UK and Belgium have identified a previously unknown genetic cause of a rare form of diabetes that develops in newborn babies, offering new insight into how insulin-producing cells function in early life. The discovery was made by scientists at the University of Exeter , working alongside colleagues at Belgium’s Université Libre de Bruxelles (ULB) . Their research shows that mutations in a little-known gene, TMEM167A , can cause insulin-producing cells in th

Image courtesy of Abbott Diabetes Care Inc. Unlike traditional food-logging tools that only assess meals after they are eaten, Libre Assist uses AI to help PWD understand how foods may affect their glucose levels before they eat. Built directly into the Libre app, the new feature allows users to: 📸 Snap a photo of their meal or enter a text description of foods; 🧠 AI predicts the meal’s potential glucose impact , displaying a colour-coded rating system — green for mino

Showing Instinct sensor on upper arm. Image courtesy of Medtronic Inc. Medtronic has received FDA clearance for a new mobile app designed to connect its smart insulin pens with glucose sensing technology developed by Abbott, marking another step towards more connected diabetes management for people who do not use a pump. The app, called MiniMed™ Go , links Medtronic’s smart insulin pens with the Instinct sensor by Abbott , enabling users to view glucose levels alongside insul

For years, closed-loop technology has promised to ease the burden of type 1 diabetes. Now, a new development from CamDiab Ltd  suggests that promise may be moving closer to reality. Following approval from its notified body, CamDiab has announced progress towards what it describes as the world’s first commercially available fully closed-loop insulin delivery algorithm  — a system designed to operate without carbohydrate counting or pre-meal bolusing . For people living with t

News that Roche are to invest $550 million in US manufacturing hub to produce CGMs.

News of award for Eversense 365 implantable CGM.

A new partnership between Senseonics and twist will enable new option for automated insulin delivery (AID) system.

A recent study suggests that airplane flights could affect the performance of insulin pumps.

News of FDA approval for Medtroinic's Simplera Sync sensor that now pairs with the MiniMed™ 780G insulin pump,

Image courtesy of Dexcom Inc. The FDA have now approved the new Dexcom G7 15 day CGM in the US. With the grace period of 12 hours, it...

SiBionics unveil their new GS3 CGM, now approved with the CE mark at this year’s ATTD in Amsterdam.

News that the users of FreeStyle Libre 3 will need to switch to the 3 Plus CGM by the end of 2025.

Diabetes related news from the event held in 2025.

Dexcom's recent financial filings revealed that they had received a warning letter from the FDA.